Auro Laboratories Limited was incorporated as a Private Limited Company on 26th May 1989 with the Registrar of Companies, Maharashtra at Bombay. Later on the Company has been converted into a Limited Company on 13th January 1994 vide resolution dated 21st September, 1993. The Company is promoted by Shri Sharat Deorah and Shri Satish Deorah. After incorporation the Company took all effective steps to set up the manufacturing facilities at Tarapur, Maharashtra by acquiring on lease a suitable plot of land at MIDC Industrial Area and with the aid of State Industrial & Investment Corporation of Maharashtra (SICOM) & Maharashtra State Finance Corporation (MSFC). The Company was successful in implementing the project and started its commercial production on 14th July, 1992. The Company is engaged in the manufacturing and trading of TRIMETHOPRIM (lP/BP/USP), a bulk drug. TMP is an antibacterial drug and is used in combination with SULPHAMETHOXAZOLE (SMX). The plant of the Company is located at K-56, MIDC Industrial Area, Tarapur, Boisar, Dist. Thane, Maharashtra with production capacity of 60 TPA of TMP. The Company is managed by the Board of Directors which includes well experienced businessmen and professionals, Shri Sharat Deorah, the Promoter-Director of the Company is the Managing Director. He possesses experience of various business activities for more than 2 decades. This includes road transport, tea warehousing and manufacturing and exports of bulk drugs. Shri Satish Deorah is the younger brother of Shri Sharat Deorah. He too holds experience spanning over more than 17 years in the business activities of transport, tea warehousing and manufacturing and exports of bulk drugs. Shri Sharat Deorah is stationed at Bombay whereas Shri Satish Deorah at Calcutta. The Company is now planning to undertake the project for expansion of production capacity of TMP from the existing 60 TPA to 200 TPA. Besides, the Company is also planning for backward integration by commencing the production of 3-4-5 TRIMETHOXYBENZALDEHYDE (TMBA), which is the basic raw material for the production of TMP. The Company has already received the Letter of Intent for the production of 3-4-5 TMBA vide the Letter of Secretariat for Industrial Approvals, Dept. of Industrial Development, Ministry of Industry, Govt. of India bearing No. LI:34 (1994) dated 11th January 1994. The Company has further made an application to the Central Government for the amendment of the licence with respect to increase in the production capacity of 3-4-5 TMBA. The plant will have a capcity of 175 TPA of the production of 3-4-5 TMBA from 275 TPA of Gallic Acid, which will be consumed entirely by the Company. Out of the total production, 50% of TMP would be exported During the year 1993-94, the Company made export worth Rs. 45 lacs and is planning to achieve an export target of Rs. 1.50 crores during the current year. So far, the Company has been involved in the manufacturing and trading of TMP, a bulk drug. One of the group companies, Auro Impex Private Limited has a very successful track record in the exports of bulk drug items. With a view to reap benefits of the backward integration, the Company is now planning to commence manufacturing of 3-4-5 TMBA. MAIN OBJECTS The main objects of the Company as set out in its Memorandum of Association are as follows : 1. To manufacture, process, derive, buy, sell, import, export, or otherwise deal in pharmaceutical, medicinal, diagnostic, antibiotic, antiseptic, disinfectants, optical, biological, immunological, therapeutic and healthcare products, preparations, compounds and intermediates. 2. To manufacture, process, derive, buy, sell, import, export or otherwise deal in cosmetics whether herbal or otherwise hair, skin, nail or other beauty preparations, perfumes, aromatic chemicals, toiletories, deodorants, hair dyes and hygienic house hold consumer products. 2006 -Received Certificate of Suitability (COS) of Metformin Hydrochloride from EDQM.